GG2 intermediate risk prostate cancer - population-based analysis of AS outcomes confirms worse cancer-specific and overall-survival compared to active treatment

• N. Bowler,
• A. Schneider,
• H. Goldberg,
• J.R. Mark,
• E.J. Trabulsi,
• C.D. Lallas,
• L.G. Gomella,
• T. Chandrasekar

Affiliations

N. Bowler

A. Schneider

H. Goldberg

J.R. Mark

E.J. Trabulsi

C.D. Lallas

L.G. Gomella

T. Chandrasekar